Siolta Therapeutics
PrivateLast Round
Series C
Feb 23, 2024
Total Funding Raised
$44.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Siolta Therapeutics is a biotechnology company that develops microbiome-based live biotherapeutic products to prevent and treat inflammatory and atopic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Siolta Therapeutics Comparables
Compare Siolta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MatriSys Bioscience | 83% | |
| Vedanta Biosciences | 81% | |
| Microbiotica | 79% | |
Siolta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 23, 2024 | ||||
| Grant | Feb 9, 2022 | ||||
| Series B | Sep 22, 2020 |
Siolta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | Series B, Series C |
| National Institute of Allergy and Infectious Diseases | Grant |
| TIME Ventures | Series C |
| TIME Ventures | Series C |
| Khosla Ventures | Series B, Series A, Series C |
| Seventure Partners | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 84% MoM, from 1.1K to 2K.
- Feb 23, 2024
$12M round led by Khosla Ventures and SymBiosis Capital Management.
Siolta Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Siolta Therapeutics's valuation, stock price, and market status.